{"id":"https://openalex.org/W1574436489","doi":null,"title":"Desenvolvimento de excipiente espec\u00edfico para capsulas de nifedipina preparadas magistralmente: parte I","display_name":"Desenvolvimento de excipiente espec\u00edfico para capsulas de nifedipina preparadas magistralmente: parte I","alternate_titles":[],"publication_year":2009,"publication_date":"2009-09-01","ids":{"openalex":"https://openalex.org/W1574436489","mag":"1574436489"},"language":"pt","primary_location":{"id":"pmh:oai:doaj.org/article:2552c76bec044047b85c721812205fab","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2552c76bec044047b85c721812205fab","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Revista de Ci\u00eancias Farmac\u00eauticas B\u00e1sica e Aplicada, Vol 30, Iss 3, Pp 257-261 (2010)","raw_type":"article"},"parent_works":[],"lineage":["https://openalex.org/W1574436489"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/2552c76bec044047b85c721812205fab","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054911824","display_name":"Kleber Jord\u00e3o Souza","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KLEBER JORD\u00e3O DE SOUZA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066639702","display_name":"Patr\u00edcia Vidal de Al\u00e9ssio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"PATR\u00edCIA VIDAL DE AL\u00e9SSIO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075631564","display_name":"Ana Julia Pereira Santinho Gomes","orcid":"https://orcid.org/0000-0003-4563-2194","observed_orcids":["https://orcid.org/0000-0003-4563-2194"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ANA J\u00faLIA PEREIRA SANTINHO GOMES","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.8866999745368958,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.8866999745368958,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.05040000006556511,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.02319999970495701,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.9409999847412109},{"id":"https://openalex.org/keywords/capsules","display_name":"capsules","score":0.5590000152587891},{"id":"https://openalex.org/keywords/magistral-formulations","display_name":"magistral formulations","score":0.7139999866485596},{"id":"https://openalex.org/keywords/pharmaceutical-excipients","display_name":"pharmaceutical excipients","score":0.6430000066757202},{"id":"https://openalex.org/keywords/dissolution-testing","display_name":"dissolution testing","score":0.5720000267028809},{"id":"https://openalex.org/keywords/content-uniformity","display_name":"content uniformity","score":0.902999997138977},{"id":"https://openalex.org/keywords/tween-80","display_name":"Tween 80","score":0.9520000219345093}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2872275114059448},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2004152238368988}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:doaj.org/article:2552c76bec044047b85c721812205fab","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2552c76bec044047b85c721812205fab","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Revista de Ci\u00eancias Farmac\u00eauticas B\u00e1sica e Aplicada, Vol 30, Iss 3, Pp 257-261 (2010)","raw_type":"article"},{"id":"pmh:oai:doaj.org/article:2cb84964942a456998ed76a019de4fee","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2cb84964942a456998ed76a019de4fee","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Revista de Ci\u00eancias Farmac\u00eauticas B\u00e1sica e Aplicada, Vol 30, Iss 3 (2009)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:2552c76bec044047b85c721812205fab","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2552c76bec044047b85c721812205fab","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Revista de Ci\u00eancias Farmac\u00eauticas B\u00e1sica e Aplicada, Vol 30, Iss 3, Pp 257-261 (2010)","raw_type":"article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.7246000170707703,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1498305210","https://openalex.org/W1555994455","https://openalex.org/W1969733709","https://openalex.org/W1993838151","https://openalex.org/W2052684858","https://openalex.org/W2074618746","https://openalex.org/W2101171473","https://openalex.org/W2410165999"],"related_works":["https://openalex.org/W7215623942","https://openalex.org/W1969733709","https://openalex.org/W2300563680","https://openalex.org/W2312558546","https://openalex.org/W2382172781","https://openalex.org/W7215280763","https://openalex.org/W2572456580","https://openalex.org/W7217245698","https://openalex.org/W2348039378"],"abstract_inverted_index":{"O":[0],"presente":[1],"trabalho":[2],"tem":[3],"o":[4,17,20,165,173],"objetivo":[5],"de":[6,13,33,35,37,47,61,75,81,91,93,96,120,125,127,132,141,156,175,216,227,235],"desenvolver":[7],"um":[8,62],"excipiente":[9],"espec\u00edfico":[10],"para":[11,109,208],"c\u00e1psula":[12],"nifedipina":[14],"preparada":[15],"magistralmente,":[16],"qual":[18],"permita":[19],"cumprimento":[21],"dos":[22,111],"requisitos":[23],"farmacop\u00e9icos":[24],"e":[25,56,69,95,161,190],"legais,":[26],"conforme":[27],"preconiza":[28],"a":[29,209,214,219,259,318,386,470],"RDC":[30,286],"n\u00ba":[31],"87":[32,287],"21":[34],"novembro":[36],"2008.":[38,291],"Para":[39],"isso,":[40],"foram":[41,87],"propostas":[42,195],"6":[43,295],"formula\u00e7\u00f5es":[44,135,152],"contendo":[45],"10mg":[46,300],"nifedipina,":[48,178],"sendo,":[49],"quatro":[50],"destas,":[51],"denominadas":[52],"A,":[53],"B,":[54,309],"C":[55,310],"D,":[57],"baseadas":[58,71],"na":[59,102,159,162,167],"composi\u00e7\u00e3o":[60],"medicamento":[63],"industrializado,":[64],"enquanto":[65],"as":[66,134,187,193,421,449],"formula\u00e7\u00f5es,":[67],"E":[68,323,397,431],"F":[70,325,399],"em":[72,77,144],"sugest\u00f5es":[73],"opcionais":[74],"excipientes":[76],"fun\u00e7\u00e3o":[78],"do":[79,211,221],"Sistema":[80],"Classifica\u00e7\u00e3o":[82],"Biofarmac\u00eautico.":[83],"Em":[84],"seguida,":[85],"estas":[86],"submetidas":[88],"aos":[89],"testes":[90],"uniformidade":[92,126],"conte\u00fado":[94],"dissolu\u00e7\u00e3o":[97,176],"utilizando":[98],"absor\u00e7\u00e3o":[99],"por":[100],"espectrofotometria":[101],"regi\u00e3o":[103],"da":[104,177],"ultravioleta":[105],"(\u03bb":[106],"=":[107,116,358,367],"236nm)":[108,359],"obten\u00e7\u00e3o":[110],"resultados.":[112],"As":[113],"amostras":[114],"(n":[115,366],"3)":[117,368],"se":[118],"comportaram":[119],"forma":[121],"adequada":[122,207],"no":[123,130,424],"teste":[124,131],"conte\u00fado,":[128],"entretanto,":[129],"dissolu\u00e7\u00e3o,":[133],"n\u00e3o":[136,171,180,200],"apresentaram":[137],"uma":[138,149],"quantidade":[139],"satisfat\u00f3ria":[140],"ativo":[142],"dissolvido":[143],"20":[145,218,393,457],"min.":[146],"Pode-se":[147],"observar":[148],"evolu\u00e7\u00e3o":[150],"das":[151],"quanto":[153],"\u00e0":[154],"presen\u00e7a":[155],"Tween":[157,406],"80":[158],"E,":[160],"F.":[163,433],"Entretanto,":[164],"aumento":[166],"concentra\u00e7\u00e3o":[168],"deste":[169,184],"agente,":[170],"ampliou":[172],"perfil":[174],"pois":[179],"houve":[181],"diferen\u00e7a":[182],"significativa":[183],"par\u00e2metro":[185],"entre":[186],"duas":[188],"(E":[189],"F).":[191],"Dentre":[192],"f\u00f3rmulas":[194],"neste":[196],"trabalho,":[197],"concluiu-se":[198],"que":[199,205,224],"foi":[201],"poss\u00edvel":[202],"determinar":[203],"uma,":[204],"fosse":[206],"aprova\u00e7\u00e3o":[210],"produto,":[212],"com":[213],"libera\u00e7\u00e3o":[215],"apenas":[217],"40%":[220,459],"ativo,":[222],"indicando":[223],"h\u00e1":[225],"necessidade":[226],"novos":[228],"estudos.":[229],"Palavras":[230],"\u2013":[231],"chave:":[232],"Nifedipina.":[233],"Controle":[234],"Qualidade.":[236],"Estudo":[237],"In":[238,479],"Vitro.":[239],"ABSTRACT":[240],"Development":[241],"of":[242,253,273,288,301,317,389,405,418,439,460],"specific":[243,260],"excipient":[244,261],"for":[245,262,297,451,472],"compounded":[246,264],"nifedipine":[247,265,302],"capsules.":[248],"part":[249],"I":[250],"The":[251,364,395],"objective":[252],"this":[254,293,428,444],"study":[255],"was":[256,423,435,464],"to":[257,347,360,371,458],"develop":[258],"extemporaneously":[263],"capsules,":[266],"which":[267],"would":[268],"comply":[269],"with":[270,335,402],"the":[271,274,277,305,315,336,342,362,378,381,410,415,419,440,461],"specifications":[272],"pharmacopoeia":[275],"and":[276,311,324,350,398,432],"legal":[278],"requisites,":[279],"set":[280],"out":[281],"in":[282,333,377,392,427,443],"Brazilian":[283],"Health":[284],"Regulation":[285],"November":[289],"21,":[290],"To":[292],"end,":[294],"formulations":[296,322,382,396,441],"capsules":[298,344],"containing":[299],"were":[303,326,345,369,400],"proposed,":[304],"first":[306],"four":[307],"(A,":[308],"D)being":[312],"based":[313,327],"on":[314,328],"composition":[316],"manufactured":[319],"medicine,":[320],"while":[321],"an":[329],"alternative":[330],"excipient,":[331],"suggested":[332],"accordance":[334],"Biopharmaceutical":[337],"Classification":[338],"System.":[339],"After":[340],"preparation,":[341],"formulated":[343],"subjected":[346],"content":[348,374],"uniformity":[349],"dissolution":[351,379,416],"tests,":[352],"using":[353],"UV":[354],"absorption":[355],"spectrophotometry":[356],"(\uf06c":[357],"assay":[361],"drug.":[363],"samples":[365],"found":[370],"have":[372],"adequate":[373],"uniformity;":[375],"however,":[376],"test,":[380],"did":[383,412],"not":[384,413],"show":[385],"satisfactory":[387],"quantity":[388],"dissolved":[390],"drug":[391],"minutes.":[394],"designed":[401],"differing":[403],"amounts":[404],"80.":[407],"However,":[408],"increasing":[409],"concentration":[411],"improve":[414],"profile":[417],"nifedipine,":[420],"there":[422,468],"significant":[425],"difference":[426],"parameter":[429],"between":[430],"It":[434],"concluded":[436],"that":[437,455,467],"none":[438],"proposed":[442],"paper":[445],"could":[446],"be":[447],"indicated":[448],"suitable":[450],"product":[452],"approval,":[453],"given":[454],"only":[456],"active":[462],"component":[463],"released,":[465],"indicating":[466],"is":[469],"need":[471],"further":[473],"studies.":[474],"Keywords:":[475],"Nifedipine.":[476],"Quality":[477],"control.":[478],"vitro":[480],"study.":[481]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1574436489","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
